Develop, manufacture, and sell genomic analysis oncology diagnostics
Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies
Reimbursement for new oncology diagnostic technologies generally Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies
Drug pricing reforms generally
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG DAN RENBERG